

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | oxygen transport (GO:0015671) | 4.16785062 |
| 2 | positive regulation of histone deacetylation (GO:0031065) | 4.04509987 |
| 3 | maternal placenta development (GO:0001893) | 3.89224973 |
| 4 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.82589335 |
| 5 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.81925173 |
| 6 | lysine metabolic process (GO:0006553) | 3.80368425 |
| 7 | lysine catabolic process (GO:0006554) | 3.80368425 |
| 8 | gas transport (GO:0015669) | 3.75403737 |
| 9 | modulation by virus of host process (GO:0019054) | 3.71859074 |
| 10 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.68168560 |
| 11 | regulation of cholesterol homeostasis (GO:2000188) | 3.67385937 |
| 12 | cysteine metabolic process (GO:0006534) | 3.63173823 |
| 13 | modulation by symbiont of host cellular process (GO:0044068) | 3.62292101 |
| 14 | 2-oxoglutarate metabolic process (GO:0006103) | 3.61334112 |
| 15 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.59661572 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.56018210 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.56018210 |
| 18 | cellular response to virus (GO:0098586) | 3.53517015 |
| 19 | negative regulation of cell size (GO:0045792) | 3.49062132 |
| 20 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.40054839 |
| 21 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.38278500 |
| 22 | apoptotic process involved in morphogenesis (GO:0060561) | 3.36209929 |
| 23 | valine metabolic process (GO:0006573) | 3.33182051 |
| 24 | L-phenylalanine metabolic process (GO:0006558) | 3.28873582 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.28873582 |
| 26 | 4-hydroxyproline metabolic process (GO:0019471) | 3.28812909 |
| 27 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.23687286 |
| 28 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.19578508 |
| 29 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.18282056 |
| 30 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.17153346 |
| 31 | urea cycle (GO:0000050) | 3.17060771 |
| 32 | urea metabolic process (GO:0019627) | 3.17060771 |
| 33 | glycine metabolic process (GO:0006544) | 3.16994717 |
| 34 | protein localization to endosome (GO:0036010) | 3.16375978 |
| 35 | negative regulation of cell killing (GO:0031342) | 3.16030657 |
| 36 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.16030657 |
| 37 | regulation of response to osmotic stress (GO:0047484) | 3.15595978 |
| 38 | low-density lipoprotein particle clearance (GO:0034383) | 3.13263430 |
| 39 | viral transcription (GO:0019083) | 3.11278685 |
| 40 | erythrocyte maturation (GO:0043249) | 3.11205582 |
| 41 | kynurenine metabolic process (GO:0070189) | 3.09264448 |
| 42 | fatty acid transmembrane transport (GO:1902001) | 3.08639278 |
| 43 | serine family amino acid catabolic process (GO:0009071) | 3.08582417 |
| 44 | peptidyl-lysine dimethylation (GO:0018027) | 3.07677629 |
| 45 | L-phenylalanine catabolic process (GO:0006559) | 3.06720246 |
| 46 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.06720246 |
| 47 | carnitine shuttle (GO:0006853) | 3.01731072 |
| 48 | negative regulation of myotube differentiation (GO:0010832) | 3.01428318 |
| 49 | regulation of chromatin binding (GO:0035561) | 3.01121063 |
| 50 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.00061264 |
| 51 | regulation of cholesterol storage (GO:0010885) | 2.99215560 |
| 52 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.97859420 |
| 53 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.97859420 |
| 54 | modulation by symbiont of host immune response (GO:0052553) | 2.97859420 |
| 55 | positive regulation by symbiont of host defense response (GO:0052509) | 2.97859420 |
| 56 | modulation by symbiont of host defense response (GO:0052031) | 2.97859420 |
| 57 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.97859420 |
| 58 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.97782698 |
| 59 | response to muramyl dipeptide (GO:0032495) | 2.96207933 |
| 60 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.95465440 |
| 61 | regulation of early endosome to late endosome transport (GO:2000641) | 2.95022048 |
| 62 | oxaloacetate metabolic process (GO:0006107) | 2.94788000 |
| 63 | alpha-linolenic acid metabolic process (GO:0036109) | 2.92873837 |
| 64 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.91806663 |
| 65 | sulfur amino acid catabolic process (GO:0000098) | 2.91251798 |
| 66 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.91182515 |
| 67 | translational termination (GO:0006415) | 2.90249958 |
| 68 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.89007769 |
| 69 | positive regulation of lipid storage (GO:0010884) | 2.88960224 |
| 70 | amino-acid betaine metabolic process (GO:0006577) | 2.88372691 |
| 71 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.88041057 |
| 72 | protein carboxylation (GO:0018214) | 2.88041057 |
| 73 | adherens junction assembly (GO:0034333) | 2.87692027 |
| 74 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.87266317 |
| 75 | nitrogen cycle metabolic process (GO:0071941) | 2.86854366 |
| 76 | positive regulation of protein deacetylation (GO:0090312) | 2.85329910 |
| 77 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.85219592 |
| 78 | negative regulation of fibrinolysis (GO:0051918) | 2.84281246 |
| 79 | regulation of fatty acid oxidation (GO:0046320) | 2.84202468 |
| 80 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.83962159 |
| 81 | response to peptidoglycan (GO:0032494) | 2.82421639 |
| 82 | glyoxylate metabolic process (GO:0046487) | 2.81998144 |
| 83 | phospholipid efflux (GO:0033700) | 2.81946257 |
| 84 | pentose-phosphate shunt (GO:0006098) | 2.81031295 |
| 85 | focal adhesion assembly (GO:0048041) | 2.78495025 |
| 86 | cell-substrate adherens junction assembly (GO:0007045) | 2.78495025 |
| 87 | regulation of ARF GTPase activity (GO:0032312) | 2.78171909 |
| 88 | negative regulation of cholesterol transport (GO:0032375) | 2.78048035 |
| 89 | negative regulation of sterol transport (GO:0032372) | 2.78048035 |
| 90 | detection of bacterium (GO:0016045) | 2.78037116 |
| 91 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.76873419 |
| 92 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.76726409 |
| 93 | regulation of triglyceride catabolic process (GO:0010896) | 2.76017454 |
| 94 | erythrocyte development (GO:0048821) | 2.75245228 |
| 95 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.74070273 |
| 96 | proline biosynthetic process (GO:0006561) | 2.73539737 |
| 97 | aspartate family amino acid catabolic process (GO:0009068) | 2.71930733 |
| 98 | activation of MAPKKK activity (GO:0000185) | 2.71827972 |
| 99 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.69843471 |
| 100 | plasma lipoprotein particle assembly (GO:0034377) | 2.69826391 |
| 101 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.69234658 |
| 102 | protein-lipid complex assembly (GO:0065005) | 2.69221671 |
| 103 | positive regulation of nuclease activity (GO:0032075) | 2.67820079 |
| 104 | aromatic amino acid family catabolic process (GO:0009074) | 2.67420827 |
| 105 | RNA stabilization (GO:0043489) | 2.67296460 |
| 106 | mRNA stabilization (GO:0048255) | 2.67296460 |
| 107 | homocysteine metabolic process (GO:0050667) | 2.66640027 |
| 108 | detection of other organism (GO:0098543) | 2.66554696 |
| 109 | tricarboxylic acid metabolic process (GO:0072350) | 2.66459049 |
| 110 | heterochromatin organization (GO:0070828) | 2.66418096 |
| 111 | negative regulation of viral release from host cell (GO:1902187) | 2.66240630 |
| 112 | regulation of gamma-delta T cell activation (GO:0046643) | 2.66034389 |
| 113 | hemoglobin metabolic process (GO:0020027) | 2.65080256 |
| 114 | plasma lipoprotein particle clearance (GO:0034381) | 2.64687227 |
| 115 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.64027596 |
| 116 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.63522960 |
| 117 | GDP-mannose metabolic process (GO:0019673) | 2.62900037 |
| 118 | negative regulation of fatty acid transport (GO:2000192) | 2.62148149 |
| 119 | mannose metabolic process (GO:0006013) | 2.61384564 |
| 120 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.60395020 |
| 121 | regulation of sequestering of triglyceride (GO:0010889) | 2.60278747 |
| 122 | translational elongation (GO:0006414) | 2.59735679 |
| 123 | fatty acid beta-oxidation (GO:0006635) | 2.58818173 |
| 124 | serine family amino acid metabolic process (GO:0009069) | 2.58733995 |
| 125 | regulation of necroptotic process (GO:0060544) | 2.58456243 |
| 126 | acetyl-CoA metabolic process (GO:0006084) | 2.56900612 |
| 127 | protein targeting to plasma membrane (GO:0072661) | 2.56891144 |
| 128 | embryonic process involved in female pregnancy (GO:0060136) | 2.56381601 |
| 129 | regulation of triglyceride metabolic process (GO:0090207) | 2.55999262 |
| 130 | regulation of leukocyte degranulation (GO:0043300) | 2.55845164 |
| 131 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 2.55573146 |
| 132 | positive regulation of myotube differentiation (GO:0010831) | 2.54824956 |
| 133 | response to laminar fluid shear stress (GO:0034616) | 2.54164464 |
| 134 | carnitine transmembrane transport (GO:1902603) | 2.53886973 |
| 135 | regulation of hippo signaling (GO:0035330) | 2.53724636 |
| 136 | * thymic T cell selection (GO:0045061) | 2.53645099 |
| 137 | fatty acid oxidation (GO:0019395) | 2.53320638 |
| 138 | positive regulation of lipid catabolic process (GO:0050996) | 2.53036594 |
| 139 | activation of JUN kinase activity (GO:0007257) | 2.51473741 |
| 140 | negative regulation of nucleotide catabolic process (GO:0030812) | 2.51376157 |
| 141 | complement activation, alternative pathway (GO:0006957) | 2.51173732 |
| 142 | positive regulation of fatty acid oxidation (GO:0046321) | 2.50661067 |
| 143 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.49786418 |
| 144 | amino-acid betaine transport (GO:0015838) | 2.49348266 |
| 145 | carnitine transport (GO:0015879) | 2.49348266 |
| 146 | ethanol oxidation (GO:0006069) | 2.48974288 |
| 147 | megakaryocyte development (GO:0035855) | 2.48764878 |
| 148 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.48720980 |
| 149 | positive regulation of Rap GTPase activity (GO:0032854) | 2.48184564 |
| 150 | protein hydroxylation (GO:0018126) | 2.46950778 |
| 151 | high-density lipoprotein particle remodeling (GO:0034375) | 2.46834012 |
| 152 | protein retention in ER lumen (GO:0006621) | 2.46693483 |
| 153 | barbed-end actin filament capping (GO:0051016) | 2.46507729 |
| 154 | cellular modified amino acid catabolic process (GO:0042219) | 2.46455976 |
| 155 | negative regulation of lipid transport (GO:0032369) | 2.46436226 |
| 156 | negative regulation of heart growth (GO:0061117) | 2.46072095 |
| 157 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.46072095 |
| 158 | modulation by virus of host morphology or physiology (GO:0019048) | 2.45960881 |
| 159 | lipid oxidation (GO:0034440) | 2.45713205 |
| 160 | negative regulation of necroptotic process (GO:0060546) | 2.45702079 |
| 161 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.45231977 |
| 162 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.45114918 |
| 163 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.44889055 |
| 164 | ribosomal small subunit assembly (GO:0000028) | 2.44662099 |
| 165 | activation of Rac GTPase activity (GO:0032863) | 2.44592753 |
| 166 | indolalkylamine catabolic process (GO:0046218) | 2.44563116 |
| 167 | tryptophan catabolic process (GO:0006569) | 2.44563116 |
| 168 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.43965651 |
| 169 | regulation of necrotic cell death (GO:0010939) | 2.43366811 |
| 170 | adenosine receptor signaling pathway (GO:0001973) | 2.42846899 |
| 171 | semaphorin-plexin signaling pathway (GO:0071526) | 2.42283811 |
| 172 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.42133122 |
| 173 | histone H4 deacetylation (GO:0070933) | 2.41609445 |
| 174 | negative regulation of striated muscle cell differentiation (GO:0051154) | 2.40230293 |
| 175 | negative regulation of glial cell proliferation (GO:0060253) | 2.38900739 |
| 176 | stress fiber assembly (GO:0043149) | 2.38432927 |
| 177 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.37876863 |
| 178 | NIK/NF-kappaB signaling (GO:0038061) | 2.35158626 |
| 179 | positive regulation of receptor recycling (GO:0001921) | 2.33254062 |
| 180 | macrophage activation involved in immune response (GO:0002281) | 2.32374315 |
| 181 | regulation of mast cell degranulation (GO:0043304) | 2.31527535 |
| 182 | regulation of extracellular matrix disassembly (GO:0010715) | 2.30139946 |
| 183 | germinal center formation (GO:0002467) | 2.29665763 |
| 184 | negative regulation of granulocyte differentiation (GO:0030853) | 2.29609290 |
| 185 | negative regulation of skeletal muscle tissue development (GO:0048642) | 2.29139467 |
| 186 | UV protection (GO:0009650) | 2.28477239 |
| 187 | positive regulation of protein dephosphorylation (GO:0035307) | 2.28335426 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.19627177 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.42610349 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.35288770 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.06739345 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.00995145 |
| 6 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.97191228 |
| 7 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.77320138 |
| 8 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.73940482 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.58877403 |
| 10 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.48919646 |
| 11 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.47896495 |
| 12 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.36176545 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.32203900 |
| 14 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.26891823 |
| 15 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.23918352 |
| 16 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.22304758 |
| 17 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.20472951 |
| 18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.18788750 |
| 19 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.06552041 |
| 20 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.01285986 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.96735928 |
| 22 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.93991767 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 1.85862420 |
| 24 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.85159171 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.81905248 |
| 26 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.78249182 |
| 27 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.67693445 |
| 28 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67130494 |
| 29 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.66839255 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.61911361 |
| 31 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.61595755 |
| 32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.58764910 |
| 33 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.58493459 |
| 34 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.54453829 |
| 35 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.52476560 |
| 36 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.48390160 |
| 37 | ATF3_27146783_Chip-Seq_COLON_Human | 1.48312379 |
| 38 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.47574270 |
| 39 | MAF_26560356_Chip-Seq_TH2_Human | 1.47179783 |
| 40 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.46603958 |
| 41 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42916565 |
| 42 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.42574487 |
| 43 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.42436497 |
| 44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40509255 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.38457956 |
| 46 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37272521 |
| 47 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.34523436 |
| 48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.33306887 |
| 49 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.31071749 |
| 50 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.29948862 |
| 51 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29442137 |
| 52 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29420183 |
| 53 | * P68_20966046_ChIP-Seq_HELA_Human | 1.29072171 |
| 54 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.28677592 |
| 55 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.27992568 |
| 56 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.27936151 |
| 57 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.27784470 |
| 58 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.27761816 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.27587516 |
| 60 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25820692 |
| 61 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.25102808 |
| 62 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24744588 |
| 63 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22924647 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.22755768 |
| 65 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.22484680 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21858824 |
| 67 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.20002334 |
| 68 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19558277 |
| 69 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.19105568 |
| 70 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18926653 |
| 71 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.18894289 |
| 72 | * BCOR_27268052_Chip-Seq_Bcells_Human | 1.18544759 |
| 73 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.17838457 |
| 74 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.17591524 |
| 75 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.16686346 |
| 76 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16368113 |
| 77 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.15968890 |
| 78 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.15637802 |
| 79 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.15574196 |
| 80 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.14347918 |
| 81 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.14026652 |
| 82 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.13730805 |
| 83 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13253872 |
| 84 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.12796922 |
| 85 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.12760111 |
| 86 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.12079443 |
| 87 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.10896088 |
| 88 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.09894189 |
| 89 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.09693446 |
| 90 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.09693446 |
| 91 | SA1_27219007_Chip-Seq_Bcells_Human | 1.09162290 |
| 92 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.08752615 |
| 93 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.08641096 |
| 94 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.07838405 |
| 95 | * MYB_26560356_Chip-Seq_TH1_Human | 1.07354165 |
| 96 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.07095757 |
| 97 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06855173 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.06844796 |
| 99 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06255537 |
| 100 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.05129221 |
| 101 | * CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.04779658 |
| 102 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.04196264 |
| 103 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03593735 |
| 104 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.03564333 |
| 105 | * BCL6_27268052_Chip-Seq_Bcells_Human | 1.03451261 |
| 106 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.03324197 |
| 107 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02467562 |
| 108 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02434797 |
| 109 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.02185815 |
| 110 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.00925433 |
| 111 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00900095 |
| 112 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.00578715 |
| 113 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.00264237 |
| 114 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.99888672 |
| 115 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.99457646 |
| 116 | SPI1_23127762_ChIP-Seq_K562_Human | 0.99394008 |
| 117 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.97791184 |
| 118 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97528091 |
| 119 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.96393790 |
| 120 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.96295802 |
| 121 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96285971 |
| 122 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95337721 |
| 123 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95145416 |
| 124 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.94251377 |
| 125 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.93806232 |
| 126 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.93751074 |
| 127 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93030910 |
| 128 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.92905419 |
| 129 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.92524172 |
| 130 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 0.90508235 |
| 131 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.90411841 |
| 132 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.89689233 |
| 133 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.89276862 |
| 134 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.89243941 |
| 135 | MYB_26560356_Chip-Seq_TH2_Human | 0.89157885 |
| 136 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88071829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 3.54833749 |
| 2 | MP0003646_muscle_fatigue | 3.34532379 |
| 3 | MP0005360_urolithiasis | 3.28776992 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.14898763 |
| 5 | MP0005058_abnormal_lysosome_morphology | 2.73534252 |
| 6 | MP0009840_abnormal_foam_cell | 2.70754533 |
| 7 | MP0005365_abnormal_bile_salt | 2.69468358 |
| 8 | MP0005083_abnormal_biliary_tract | 2.61961937 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.49641266 |
| 10 | MP0005085_abnormal_gallbladder_physiolo | 2.36695271 |
| 11 | MP0004858_abnormal_nervous_system | 2.28364851 |
| 12 | MP0008260_abnormal_autophagy | 2.22502166 |
| 13 | MP0010329_abnormal_lipoprotein_level | 2.13607780 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.09458451 |
| 15 | MP0004185_abnormal_adipocyte_glucose | 2.06948066 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 1.93522731 |
| 17 | MP0008961_abnormal_basal_metabolism | 1.91667609 |
| 18 | MP0000678_abnormal_parathyroid_gland | 1.87493974 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 1.84908450 |
| 20 | MP0003252_abnormal_bile_duct | 1.84546859 |
| 21 | MP0003300_gastrointestinal_ulcer | 1.80880159 |
| 22 | * MP0005076_abnormal_cell_differentiation | 1.76588642 |
| 23 | MP0005409_darkened_coat_color | 1.76558923 |
| 24 | MP0005666_abnormal_adipose_tissue | 1.71717542 |
| 25 | MP0003763_abnormal_thymus_physiology | 1.71671179 |
| 26 | MP0000609_abnormal_liver_physiology | 1.70026164 |
| 27 | MP0003656_abnormal_erythrocyte_physiolo | 1.69209335 |
| 28 | MP0004147_increased_porphyrin_level | 1.69044112 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.64299580 |
| 30 | MP0002249_abnormal_larynx_morphology | 1.61131552 |
| 31 | MP0000751_myopathy | 1.56365289 |
| 32 | MP0003566_abnormal_cell_adhesion | 1.54805404 |
| 33 | * MP0003303_peritoneal_inflammation | 1.51223392 |
| 34 | MP0004087_abnormal_muscle_fiber | 1.50709334 |
| 35 | MP0001873_stomach_inflammation | 1.50706569 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.49330096 |
| 37 | MP0005330_cardiomyopathy | 1.45503997 |
| 38 | * MP0004130_abnormal_muscle_cell | 1.42554928 |
| 39 | * MP0005025_abnormal_response_to | 1.41761454 |
| 40 | MP0002877_abnormal_melanocyte_morpholog | 1.41335008 |
| 41 | MP0000750_abnormal_muscle_regeneration | 1.40543776 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.40533316 |
| 43 | MP0000685_abnormal_immune_system | 1.40369434 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.38541577 |
| 45 | MP0004036_abnormal_muscle_relaxation | 1.36754848 |
| 46 | MP0008875_abnormal_xenobiotic_pharmacok | 1.35029550 |
| 47 | MP0003329_amyloid_beta_deposits | 1.33446774 |
| 48 | MP0010630_abnormal_cardiac_muscle | 1.32669749 |
| 49 | MP0002419_abnormal_innate_immunity | 1.31468049 |
| 50 | MP0000749_muscle_degeneration | 1.30454886 |
| 51 | MP0010352_gastrointestinal_tract_polyps | 1.28540225 |
| 52 | MP0003091_abnormal_cell_migration | 1.24566624 |
| 53 | MP0002269_muscular_atrophy | 1.23493666 |
| 54 | MP0003806_abnormal_nucleotide_metabolis | 1.23115042 |
| 55 | MP0005375_adipose_tissue_phenotype | 1.21900358 |
| 56 | MP0005000_abnormal_immune_tolerance | 1.20091245 |
| 57 | MP0004510_myositis | 1.19862420 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.19123033 |
| 59 | MP0004084_abnormal_cardiac_muscle | 1.18342359 |
| 60 | MP0004233_abnormal_muscle_weight | 1.17331708 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 1.17082214 |
| 62 | MP0003279_aneurysm | 1.16678872 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 1.15678038 |
| 64 | MP0002420_abnormal_adaptive_immunity | 1.13725734 |
| 65 | MP0003436_decreased_susceptibility_to | 1.13384482 |
| 66 | MP0001819_abnormal_immune_cell | 1.13181622 |
| 67 | MP0004381_abnormal_hair_follicle | 1.08960019 |
| 68 | MP0000490_abnormal_crypts_of | 1.08911087 |
| 69 | MP0005332_abnormal_amino_acid | 1.08054204 |
| 70 | * MP0000858_altered_metastatic_potential | 1.07585651 |
| 71 | MP0005670_abnormal_white_adipose | 1.07393247 |
| 72 | MP0001348_abnormal_lacrimal_gland | 1.06691903 |
| 73 | MP0010307_abnormal_tumor_latency | 1.05893312 |
| 74 | MP0001849_ear_inflammation | 1.05806395 |
| 75 | MP0000733_abnormal_muscle_development | 1.05220197 |
| 76 | MP0003828_pulmonary_edema | 1.04680792 |
| 77 | MP0002106_abnormal_muscle_physiology | 1.04656269 |
| 78 | MP0005464_abnormal_platelet_physiology | 1.04634608 |
| 79 | * MP0002429_abnormal_blood_cell | 1.03982516 |
| 80 | MP0002723_abnormal_immune_serum | 1.03623403 |
| 81 | MP0002796_impaired_skin_barrier | 1.02695114 |
| 82 | MP0002998_abnormal_bone_remodeling | 1.02607435 |
| 83 | * MP0001545_abnormal_hematopoietic_system | 1.02585162 |
| 84 | * MP0005397_hematopoietic_system_phenotyp | 1.02585162 |
| 85 | MP0001533_abnormal_skeleton_physiology | 1.01862508 |
| 86 | MP0000747_muscle_weakness | 1.01662302 |
| 87 | * MP0009931_abnormal_skin_appearance | 1.00784378 |
| 88 | * MP0005220_abnormal_exocrine_pancreas | 1.00624785 |
| 89 | * MP0009278_abnormal_bone_marrow | 0.99543849 |
| 90 | * MP0000598_abnormal_liver_morphology | 0.99126218 |
| 91 | * MP0000716_abnormal_immune_system | 0.98755784 |
| 92 | MP0003693_abnormal_embryo_hatching | 0.98246843 |
| 93 | MP0002452_abnormal_antigen_presenting | 0.98183665 |
| 94 | MP0005451_abnormal_body_composition | 0.95953327 |
| 95 | MP0003866_abnormal_defecation | 0.95839731 |
| 96 | MP0002089_abnormal_postnatal_growth/wei | 0.95687897 |
| 97 | MP0002971_abnormal_brown_adipose | 0.95229694 |
| 98 | MP0001835_abnormal_antigen_presentation | 0.95136647 |
| 99 | MP0008995_early_reproductive_senescence | 0.94715294 |
| 100 | MP0003221_abnormal_cardiomyocyte_apopto | 0.93233647 |
| 101 | * MP0006036_abnormal_mitochondrial_physio | 0.93205401 |
| 102 | MP0000537_abnormal_urethra_morphology | 0.93047778 |
| 103 | MP0009643_abnormal_urine_homeostasis | 0.91283193 |
| 104 | MP0000759_abnormal_skeletal_muscle | 0.90543690 |
| 105 | MP0005501_abnormal_skin_physiology | 0.90482872 |
| 106 | MP0002970_abnormal_white_adipose | 0.88489057 |
| 107 | MP0001730_embryonic_growth_arrest | 0.87381455 |
| 108 | MP0008775_abnormal_heart_ventricle | 0.87173287 |
| 109 | MP0002132_abnormal_respiratory_system | 0.86883554 |
| 110 | MP0002933_joint_inflammation | 0.86468821 |
| 111 | MP0000015_abnormal_ear_pigmentation | 0.86337982 |
| 112 | MP0000681_abnormal_thyroid_gland | 0.86168897 |
| 113 | MP0009115_abnormal_fat_cell | 0.85179456 |
| 114 | MP0003879_abnormal_hair_cell | 0.85120687 |
| 115 | MP0005387_immune_system_phenotype | 0.83829675 |
| 116 | MP0001790_abnormal_immune_system | 0.83829675 |
| 117 | MP0001800_abnormal_humoral_immune | 0.82928249 |
| 118 | MP0001958_emphysema | 0.81644666 |
| 119 | MP0004947_skin_inflammation | 0.80628064 |
| 120 | MP0002166_altered_tumor_susceptibility | 0.80412264 |
| 121 | MP0009672_abnormal_birth_weight | 0.80406995 |
| 122 | MP0000604_amyloidosis | 0.79414380 |
| 123 | * MP0003111_abnormal_nucleus_morphology | 0.78900738 |
| 124 | MP0000465_gastrointestinal_hemorrhage | 0.78536985 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.77973991 |
| 126 | * MP0002722_abnormal_immune_system | 0.77478132 |
| 127 | * MP0002088_abnormal_embryonic_growth/wei | 0.77455299 |
| 128 | MP0001544_abnormal_cardiovascular_syste | 0.76954440 |
| 129 | MP0005385_cardiovascular_system_phenoty | 0.76954440 |
| 130 | * MP0003984_embryonic_growth_retardation | 0.76827527 |
| 131 | MP0005334_abnormal_fat_pad | 0.75362491 |
| 132 | MP0003567_abnormal_fetal_cardiomyocyte | 0.74885286 |
| 133 | MP0001727_abnormal_embryo_implantation | 0.74738240 |
| 134 | * MP0004808_abnormal_hematopoietic_stem | 0.73935967 |
| 135 | MP0008438_abnormal_cutaneous_collagen | 0.73916426 |
| 136 | MP0003453_abnormal_keratinocyte_physiol | 0.73584864 |
| 137 | MP0002405_respiratory_system_inflammati | 0.72810633 |
| 138 | * MP0002398_abnormal_bone_marrow | 0.72077840 |
| 139 | MP0003045_fibrosis | 0.71071050 |
| 140 | MP0005377_hearing/vestibular/ear_phenot | 0.71064815 |
| 141 | MP0003878_abnormal_ear_physiology | 0.71064815 |
| 142 | * MP0000689_abnormal_spleen_morphology | 0.70052340 |
| 143 | * MP0002019_abnormal_tumor_incidence | 0.69469445 |
| 144 | * MP0002078_abnormal_glucose_homeostasis | 0.68793379 |
| 145 | * MP0002086_abnormal_extraembryonic_tissu | 0.68675850 |
| 146 | MP0004197_abnormal_fetal_growth/weight/ | 0.68410195 |
| 147 | * MP0000703_abnormal_thymus_morphology | 0.68357276 |
| 148 | MP0000003_abnormal_adipose_tissue | 0.68338643 |
| 149 | MP0008469_abnormal_protein_level | 0.68287111 |
| 150 | MP0008874_decreased_physiological_sensi | 0.67768698 |
| 151 | MP0001661_extended_life_span | 0.67548061 |
| 152 | MP0004264_abnormal_extraembryonic_tissu | 0.67185223 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 3.82686393 |
| 2 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.52831117 |
| 3 | Increased connective tissue (HP:0009025) | 3.30795356 |
| 4 | Polycythemia (HP:0001901) | 3.30508731 |
| 5 | Ulnar bowing (HP:0003031) | 3.26504727 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.09829986 |
| 7 | Xanthomatosis (HP:0000991) | 3.01027141 |
| 8 | Ventricular tachycardia (HP:0004756) | 2.92834591 |
| 9 | Myoglobinuria (HP:0002913) | 2.88421109 |
| 10 | Difficulty climbing stairs (HP:0003551) | 2.85490097 |
| 11 | Reticulocytosis (HP:0001923) | 2.85313444 |
| 12 | Obstructive sleep apnea (HP:0002870) | 2.82547980 |
| 13 | Sudden death (HP:0001699) | 2.80346111 |
| 14 | Muscle fiber splitting (HP:0003555) | 2.78921937 |
| 15 | Hyperacusis (HP:0010780) | 2.76197127 |
| 16 | Hyporeflexia of lower limbs (HP:0002600) | 2.74016744 |
| 17 | Thin bony cortex (HP:0002753) | 2.72336599 |
| 18 | Hemorrhage of the eye (HP:0011885) | 2.70653842 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 2.64845048 |
| 20 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.63705404 |
| 21 | Ketosis (HP:0001946) | 2.60494534 |
| 22 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.60241145 |
| 23 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.60045816 |
| 24 | Myocardial infarction (HP:0001658) | 2.59808681 |
| 25 | Exercise-induced myalgia (HP:0003738) | 2.55046248 |
| 26 | Poikilocytosis (HP:0004447) | 2.54930734 |
| 27 | Stridor (HP:0010307) | 2.54363098 |
| 28 | Distal lower limb muscle weakness (HP:0009053) | 2.52793698 |
| 29 | Distal lower limb amyotrophy (HP:0008944) | 2.49967322 |
| 30 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.47313180 |
| 31 | Difficulty running (HP:0009046) | 2.45219481 |
| 32 | Hyperglycinuria (HP:0003108) | 2.43390326 |
| 33 | Cerebral aneurysm (HP:0004944) | 2.41695620 |
| 34 | Complement deficiency (HP:0004431) | 2.39399815 |
| 35 | Lymphangioma (HP:0100764) | 2.38744690 |
| 36 | Insomnia (HP:0100785) | 2.38676662 |
| 37 | Abnormality of the Achilles tendon (HP:0005109) | 2.37155869 |
| 38 | Abnormality of reticulocytes (HP:0004312) | 2.36845417 |
| 39 | Diaphragmatic weakness (HP:0009113) | 2.33163159 |
| 40 | Hyperammonemia (HP:0001987) | 2.31446132 |
| 41 | Rhabdomyolysis (HP:0003201) | 2.31273489 |
| 42 | Abnormality of complement system (HP:0005339) | 2.30209203 |
| 43 | Turricephaly (HP:0000262) | 2.29823067 |
| 44 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.29467996 |
| 45 | Impaired platelet aggregation (HP:0003540) | 2.29082288 |
| 46 | Abnormal platelet function (HP:0011869) | 2.29082288 |
| 47 | Cholelithiasis (HP:0001081) | 2.28189475 |
| 48 | Asymmetric septal hypertrophy (HP:0001670) | 2.28132107 |
| 49 | Exercise-induced muscle cramps (HP:0003710) | 2.28075415 |
| 50 | Spastic diplegia (HP:0001264) | 2.27727994 |
| 51 | Broad face (HP:0000283) | 2.27052923 |
| 52 | Hypertensive crisis (HP:0100735) | 2.24208840 |
| 53 | * Abnormality of the nasal mucosa (HP:0000433) | 2.22440598 |
| 54 | Mitral valve prolapse (HP:0001634) | 2.20123153 |
| 55 | Easy fatigability (HP:0003388) | 2.19611689 |
| 56 | Intrahepatic cholestasis (HP:0001406) | 2.19369754 |
| 57 | Multiple enchondromatosis (HP:0005701) | 2.17432211 |
| 58 | Late onset (HP:0003584) | 2.16925140 |
| 59 | Hypoalphalipoproteinemia (HP:0003233) | 2.16009960 |
| 60 | Achilles tendon contracture (HP:0001771) | 2.15896402 |
| 61 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.14690252 |
| 62 | Subaortic stenosis (HP:0001682) | 2.14690252 |
| 63 | Microcytic anemia (HP:0001935) | 2.13796828 |
| 64 | Recurrent abscess formation (HP:0002722) | 2.12881599 |
| 65 | Type 1 muscle fiber predominance (HP:0003803) | 2.12766051 |
| 66 | Hyperglycinemia (HP:0002154) | 2.11376705 |
| 67 | Gout (HP:0001997) | 2.09900564 |
| 68 | Disproportionate tall stature (HP:0001519) | 2.09656546 |
| 69 | Abnormality of glycine metabolism (HP:0010895) | 2.09369564 |
| 70 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.09369564 |
| 71 | Ketoacidosis (HP:0001993) | 2.09034660 |
| 72 | Chronic obstructive pulmonary disease (HP:0006510) | 2.08944230 |
| 73 | Obstructive lung disease (HP:0006536) | 2.08944230 |
| 74 | Atrioventricular block (HP:0001678) | 2.08638720 |
| 75 | Increased IgE level (HP:0003212) | 2.06979096 |
| 76 | Joint hemorrhage (HP:0005261) | 2.06414666 |
| 77 | Conjunctival hamartoma (HP:0100780) | 2.05716274 |
| 78 | Papilloma (HP:0012740) | 2.04410098 |
| 79 | Verrucae (HP:0200043) | 2.04410098 |
| 80 | Recurrent bacterial skin infections (HP:0005406) | 2.03665654 |
| 81 | Annular pancreas (HP:0001734) | 2.02687125 |
| 82 | * Nasal polyposis (HP:0100582) | 2.02406492 |
| 83 | Thrombocytosis (HP:0001894) | 2.02231707 |
| 84 | Hypoglycemic coma (HP:0001325) | 2.01768727 |
| 85 | Thin ribs (HP:0000883) | 2.01761448 |
| 86 | Emphysema (HP:0002097) | 2.00145599 |
| 87 | Abnormal platelet volume (HP:0011876) | 1.99125190 |
| 88 | Abnormal gallbladder morphology (HP:0012437) | 1.98663920 |
| 89 | Hyperlipoproteinemia (HP:0010980) | 1.98550633 |
| 90 | Increased mean platelet volume (HP:0011877) | 1.97444492 |
| 91 | Hepatocellular carcinoma (HP:0001402) | 1.97037768 |
| 92 | Abnormal gallbladder physiology (HP:0012438) | 1.96841398 |
| 93 | Cholecystitis (HP:0001082) | 1.96841398 |
| 94 | Menorrhagia (HP:0000132) | 1.96725635 |
| 95 | Broad distal phalanx of finger (HP:0009836) | 1.96191319 |
| 96 | Aneurysm (HP:0002617) | 1.95842771 |
| 97 | Pseudobulbar signs (HP:0002200) | 1.93346646 |
| 98 | Bulbar palsy (HP:0001283) | 1.93033222 |
| 99 | Gastrointestinal inflammation (HP:0004386) | 1.93006660 |
| 100 | Vertebral compression fractures (HP:0002953) | 1.92489646 |
| 101 | Abnormal hemoglobin (HP:0011902) | 1.91777180 |
| 102 | Hypertriglyceridemia (HP:0002155) | 1.91385242 |
| 103 | Testicular atrophy (HP:0000029) | 1.90747485 |
| 104 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.90616488 |
| 105 | Polygenic inheritance (HP:0010982) | 1.90462374 |
| 106 | Calf muscle hypertrophy (HP:0008981) | 1.89565999 |
| 107 | Increased density of long bones (HP:0006392) | 1.89562602 |
| 108 | Gingivitis (HP:0000230) | 1.88613031 |
| 109 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.88124924 |
| 110 | Genu recurvatum (HP:0002816) | 1.88114964 |
| 111 | Long palpebral fissure (HP:0000637) | 1.87685819 |
| 112 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.87505418 |
| 113 | Hypochromic microcytic anemia (HP:0004840) | 1.87468318 |
| 114 | Angiofibromas (HP:0010615) | 1.87329143 |
| 115 | Adenoma sebaceum (HP:0009720) | 1.87329143 |
| 116 | Long toe (HP:0010511) | 1.87013297 |
| 117 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.86695770 |
| 118 | Metaphyseal cupping (HP:0003021) | 1.86054143 |
| 119 | Abnormality of the gallbladder (HP:0005264) | 1.85829549 |
| 120 | Hypercholesterolemia (HP:0003124) | 1.85136708 |
| 121 | Abnormal cartilage morphology (HP:0002763) | 1.85117342 |
| 122 | Abnormality of iron homeostasis (HP:0011031) | 1.84479933 |
| 123 | Abnormality of macrophages (HP:0004311) | 1.83102893 |
| 124 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.83100691 |
| 125 | Lipoatrophy (HP:0100578) | 1.83074679 |
| 126 | Increased serum ferritin (HP:0003281) | 1.83069208 |
| 127 | Colitis (HP:0002583) | 1.82528978 |
| 128 | Progressive muscle weakness (HP:0003323) | 1.82131313 |
| 129 | Round ear (HP:0100830) | 1.82100343 |
| 130 | Increased cerebral lipofuscin (HP:0011813) | 1.81232635 |
| 131 | Truncus arteriosus (HP:0001660) | 1.81088784 |
| 132 | Spontaneous hematomas (HP:0007420) | 1.81025220 |
| 133 | Cerebral inclusion bodies (HP:0100314) | 1.79937723 |
| 134 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.79483259 |
| 135 | Back pain (HP:0003418) | 1.78961401 |
| 136 | Abnormality of the thoracic spine (HP:0100711) | 1.78107868 |
| 137 | Ulnar deviation of the wrist (HP:0003049) | 1.78042247 |
| 138 | Gastrointestinal dysmotility (HP:0002579) | 1.77735467 |
| 139 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.77685435 |
| 140 | Hypolipoproteinemia (HP:0010981) | 1.77443508 |
| 141 | Bowing of the arm (HP:0006488) | 1.76187968 |
| 142 | Bowed forearm bones (HP:0003956) | 1.76187968 |
| 143 | Prolonged partial thromboplastin time (HP:0003645) | 1.76055741 |
| 144 | Ileus (HP:0002595) | 1.75083468 |
| 145 | Malnutrition (HP:0004395) | 1.74087328 |
| 146 | Bowel incontinence (HP:0002607) | 1.73484045 |
| 147 | Myopathic facies (HP:0002058) | 1.73349042 |
| 148 | Thoracic kyphosis (HP:0002942) | 1.72755087 |
| 149 | Abnormality of purine metabolism (HP:0004352) | 1.71706575 |
| 150 | Increased variability in muscle fiber diameter (HP:0003557) | 1.71087963 |
| 151 | Acanthocytosis (HP:0001927) | 1.70363803 |
| 152 | Inflammation of the large intestine (HP:0002037) | 1.69708656 |
| 153 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.69554032 |
| 154 | Pustule (HP:0200039) | 1.69457756 |
| 155 | Dysostosis multiplex (HP:0000943) | 1.69303220 |
| 156 | Mitral regurgitation (HP:0001653) | 1.69247059 |
| 157 | Shallow orbits (HP:0000586) | 1.69137553 |
| 158 | Hyperbilirubinemia (HP:0002904) | 1.68433264 |
| 159 | Cellulitis (HP:0100658) | 1.68176379 |
| 160 | Cervical subluxation (HP:0003308) | 1.68137536 |
| 161 | Protrusio acetabuli (HP:0003179) | 1.68074661 |
| 162 | EMG: myopathic abnormalities (HP:0003458) | 1.67302848 |
| 163 | Supernumerary nipples (HP:0002558) | 1.67158263 |
| 164 | Ragged-red muscle fibers (HP:0003200) | 1.66423165 |
| 165 | Hypercortisolism (HP:0001578) | 1.66006214 |
| 166 | Deep palmar crease (HP:0006191) | 1.65159179 |
| 167 | Lower limb amyotrophy (HP:0007210) | 1.64434058 |
| 168 | Dysmetric saccades (HP:0000641) | 1.64124687 |
| 169 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.62474315 |
| 170 | Distal upper limb amyotrophy (HP:0007149) | 1.62145056 |
| 171 | Upper limb amyotrophy (HP:0009129) | 1.62145056 |
| 172 | Nonimmune hydrops fetalis (HP:0001790) | 1.62001049 |
| 173 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.61724293 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.76947960 |
| 2 | EEF2K | 4.39411025 |
| 3 | MAP3K10 | 3.81537529 |
| 4 | PRPF4B | 3.70551500 |
| 5 | PKN2 | 3.42538134 |
| 6 | SMG1 | 3.29328375 |
| 7 | ERN1 | 2.98026359 |
| 8 | TTN | 2.83667420 |
| 9 | BCKDK | 2.55721880 |
| 10 | SIK1 | 2.33972025 |
| 11 | PTK6 | 2.27215801 |
| 12 | IRAK3 | 1.99450742 |
| 13 | NEK2 | 1.93434651 |
| 14 | MAP4K1 | 1.91669686 |
| 15 | CDK12 | 1.91187246 |
| 16 | NME2 | 1.78836484 |
| 17 | TAOK3 | 1.72547540 |
| 18 | LRRK2 | 1.68671516 |
| 19 | RIPK4 | 1.68651845 |
| 20 | ICK | 1.54160991 |
| 21 | MAP3K13 | 1.50143015 |
| 22 | FGFR4 | 1.39386880 |
| 23 | RIPK1 | 1.38209028 |
| 24 | STK10 | 1.30933549 |
| 25 | RPS6KA4 | 1.30841209 |
| 26 | SIK2 | 1.26704943 |
| 27 | PAK4 | 1.26325092 |
| 28 | MAPKAPK3 | 1.24175459 |
| 29 | CDK4 | 1.20835494 |
| 30 | IRAK4 | 1.18117980 |
| 31 | MAP3K1 | 1.16700819 |
| 32 | TYK2 | 1.14707743 |
| 33 | KSR2 | 1.13245110 |
| 34 | EPHB1 | 1.11295151 |
| 35 | NEK1 | 1.09379156 |
| 36 | STK3 | 1.07748190 |
| 37 | MTOR | 1.07011519 |
| 38 | BLK | 1.06481428 |
| 39 | MAP2K3 | 1.05775970 |
| 40 | RPS6KB2 | 1.04467938 |
| 41 | GRK6 | 1.00156359 |
| 42 | CDK6 | 0.99503619 |
| 43 | TNK2 | 0.99015159 |
| 44 | PDGFRA | 0.98918945 |
| 45 | LATS1 | 0.95357346 |
| 46 | MAP3K8 | 0.94536868 |
| 47 | CAMK1D | 0.93024138 |
| 48 | CDC42BPA | 0.92403879 |
| 49 | BMX | 0.91443257 |
| 50 | MAPK11 | 0.89228389 |
| 51 | IRAK2 | 0.88820405 |
| 52 | MAP3K11 | 0.85899787 |
| 53 | DYRK1B | 0.84754198 |
| 54 | FGFR3 | 0.84680182 |
| 55 | BTK | 0.84118463 |
| 56 | HIPK2 | 0.84111166 |
| 57 | FES | 0.83091963 |
| 58 | CAMK1G | 0.82956200 |
| 59 | PDK3 | 0.82078819 |
| 60 | PDK4 | 0.82078819 |
| 61 | PAK2 | 0.81982206 |
| 62 | STK4 | 0.81550913 |
| 63 | PIM1 | 0.80298485 |
| 64 | TBK1 | 0.78856432 |
| 65 | PRKD3 | 0.77371346 |
| 66 | JAK2 | 0.76886431 |
| 67 | MAP2K2 | 0.76820674 |
| 68 | MAP3K7 | 0.75717100 |
| 69 | ZAP70 | 0.74398396 |
| 70 | PDK1 | 0.74031295 |
| 71 | DMPK | 0.72663267 |
| 72 | CHUK | 0.72163330 |
| 73 | BRAF | 0.72162944 |
| 74 | ALK | 0.71920951 |
| 75 | ILK | 0.69693778 |
| 76 | TGFBR2 | 0.69395032 |
| 77 | MAP3K14 | 0.68233601 |
| 78 | TAOK1 | 0.68154178 |
| 79 | MAP3K6 | 0.67321321 |
| 80 | * RPS6KL1 | 0.67099782 |
| 81 | * RPS6KC1 | 0.67099782 |
| 82 | DYRK3 | 0.66316714 |
| 83 | * RPS6KA1 | 0.64780284 |
| 84 | HCK | 0.64657867 |
| 85 | CAMKK1 | 0.63141933 |
| 86 | ARAF | 0.62260690 |
| 87 | SGK3 | 0.60237543 |
| 88 | TYRO3 | 0.59938747 |
| 89 | IKBKE | 0.58856662 |
| 90 | EPHA2 | 0.58566197 |
| 91 | TLK1 | 0.58420963 |
| 92 | PRKAA1 | 0.57693544 |
| 93 | RET | 0.56245482 |
| 94 | PRKAA2 | 0.56121363 |
| 95 | CSK | 0.55945286 |
| 96 | MARK3 | 0.54899053 |
| 97 | JAK1 | 0.53823602 |
| 98 | GSK3A | 0.52993300 |
| 99 | OBSCN | 0.51470043 |
| 100 | FLT3 | 0.51110745 |
| 101 | * RPS6KA6 | 0.50335204 |
| 102 | SIK3 | 0.50008305 |
| 103 | PRKD1 | 0.48830735 |
| 104 | DAPK3 | 0.48565379 |
| 105 | TAOK2 | 0.47897153 |
| 106 | PIK3CG | 0.47379295 |
| 107 | TTK | 0.46512341 |
| 108 | AKT2 | 0.46019519 |
| 109 | CDK9 | 0.44533480 |
| 110 | PRKG2 | 0.44250649 |
| 111 | TESK2 | 0.43977761 |
| 112 | MAP3K3 | 0.43809948 |
| 113 | MAPK15 | 0.42878897 |
| 114 | AURKB | 0.42572796 |
| 115 | SYK | 0.41958668 |
| 116 | MAP2K6 | 0.41395988 |
| 117 | MAPKAPK2 | 0.40278450 |
| 118 | PHKG2 | 0.38293583 |
| 119 | PHKG1 | 0.38293583 |
| 120 | PRKD2 | 0.38243539 |
| 121 | FGR | 0.37766887 |
| 122 | TRPM7 | 0.37732754 |
| 123 | IKBKB | 0.37210151 |
| 124 | MAPK4 | 0.35763408 |
| 125 | MAPK7 | 0.35531286 |
| 126 | STK38 | 0.34770503 |
| 127 | PIM2 | 0.33604744 |
| 128 | PTK2 | 0.33388746 |
| 129 | LMTK2 | 0.33024747 |
| 130 | STK24 | 0.32529628 |
| 131 | MAPK12 | 0.32445763 |
| 132 | JAK3 | 0.32222397 |
| 133 | KDR | 0.32131406 |
| 134 | MAP2K4 | 0.32114265 |
| 135 | MARK2 | 0.30755667 |
| 136 | CAMK4 | 0.30746287 |
| 137 | ITK | 0.30271822 |
| 138 | PDPK1 | 0.29917366 |
| 139 | BRD4 | 0.29861258 |
| 140 | * RPS6KA2 | 0.29433071 |
| 141 | PDGFRB | 0.29038222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.58799451 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55567408 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.54788335 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.34720326 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.32965479 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.29733450 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.20421915 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.20131469 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.18516061 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.18314197 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.11097777 |
| 12 | Lysine degradation_Homo sapiens_hsa00310 | 1.97243225 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.91938748 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.91120041 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.81523389 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.64986517 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.64510801 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.60859004 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.58638991 |
| 20 | Insulin resistance_Homo sapiens_hsa04931 | 1.58421795 |
| 21 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.57989271 |
| 22 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.56319132 |
| 23 | Carbon metabolism_Homo sapiens_hsa01200 | 1.53066386 |
| 24 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.51676948 |
| 25 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.51439440 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.49525459 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42042328 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.40758005 |
| 29 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.40632615 |
| 30 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.38159164 |
| 31 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.37396314 |
| 32 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.33333488 |
| 33 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.33058980 |
| 34 | Leishmaniasis_Homo sapiens_hsa05140 | 1.32333664 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26751479 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.23104090 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.19938907 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.19799159 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.19615755 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.15172212 |
| 41 | Prion diseases_Homo sapiens_hsa05020 | 1.14854242 |
| 42 | Glioma_Homo sapiens_hsa05214 | 1.12577528 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12023579 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.10891090 |
| 45 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.09677216 |
| 46 | Malaria_Homo sapiens_hsa05144 | 1.09041952 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.08501504 |
| 48 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.08298920 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.07857814 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.07516962 |
| 51 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.06134861 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 1.05942790 |
| 53 | Ribosome_Homo sapiens_hsa03010 | 1.05928718 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.05634939 |
| 55 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.02981418 |
| 56 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.01556811 |
| 57 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01148657 |
| 58 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.01067365 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 1.00543087 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.00033560 |
| 61 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.99758728 |
| 62 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.98427002 |
| 63 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.98426537 |
| 64 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.98359221 |
| 65 | Influenza A_Homo sapiens_hsa05164 | 0.97232818 |
| 66 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.96693301 |
| 67 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93791879 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.92652409 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92490675 |
| 70 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.92375432 |
| 71 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.92033200 |
| 72 | Bladder cancer_Homo sapiens_hsa05219 | 0.90842397 |
| 73 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.89641486 |
| 74 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.89580323 |
| 75 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.88337484 |
| 76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.87920924 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.87498128 |
| 78 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87213641 |
| 79 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.85699591 |
| 80 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.85077605 |
| 81 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.84835658 |
| 82 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.84829342 |
| 83 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84606720 |
| 84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83864763 |
| 85 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.83459939 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.83348778 |
| 87 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82800973 |
| 88 | HTLV-I infection_Homo sapiens_hsa05166 | 0.81863368 |
| 89 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81289821 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.80931024 |
| 91 | Histidine metabolism_Homo sapiens_hsa00340 | 0.80722160 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.80362784 |
| 93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.78618165 |
| 94 | Endocytosis_Homo sapiens_hsa04144 | 0.76832509 |
| 95 | * mTOR signaling pathway_Homo sapiens_hsa04150 | 0.76760690 |
| 96 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.76250974 |
| 97 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76229616 |
| 98 | Lysosome_Homo sapiens_hsa04142 | 0.75383472 |
| 99 | Peroxisome_Homo sapiens_hsa04146 | 0.75170539 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74765496 |
| 101 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.73408175 |
| 102 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73172760 |
| 103 | Measles_Homo sapiens_hsa05162 | 0.70972494 |
| 104 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.69734624 |
| 105 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.68421540 |
| 106 | * FoxO signaling pathway_Homo sapiens_hsa04068 | 0.68176375 |
| 107 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67850611 |
| 108 | Long-term potentiation_Homo sapiens_hsa04720 | 0.65627438 |
| 109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.64702794 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.64367410 |
| 111 | * Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.64170362 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.63868972 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.63065592 |
| 114 | Viral myocarditis_Homo sapiens_hsa05416 | 0.62362309 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.61606859 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.61174610 |
| 117 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60820224 |
| 118 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59904702 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.59575037 |
| 120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.58932791 |
| 121 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56652008 |
| 122 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.56508199 |
| 123 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56248747 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55249170 |
| 125 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.55124495 |
| 126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53261334 |
| 127 | Amoebiasis_Homo sapiens_hsa05146 | 0.52528137 |
| 128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.52320831 |
| 129 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.51105309 |
| 130 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.50134781 |
| 131 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49680079 |
| 132 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.48552353 |
| 133 | Salmonella infection_Homo sapiens_hsa05132 | 0.48433062 |
| 134 | Shigellosis_Homo sapiens_hsa05131 | 0.46946470 |
| 135 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46930330 |
| 136 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46023356 |
| 137 | Focal adhesion_Homo sapiens_hsa04510 | 0.45439307 |
| 138 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45166322 |
| 139 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.44622732 |
| 140 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43750849 |
| 141 | Platelet activation_Homo sapiens_hsa04611 | 0.43681222 |
| 142 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.43007217 |
| 143 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42750645 |
| 144 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42474849 |
| 145 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42419574 |
| 146 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.42291776 |
| 147 | Endometrial cancer_Homo sapiens_hsa05213 | 0.42133528 |
| 148 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41845329 |
| 149 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41191246 |
| 150 | Galactose metabolism_Homo sapiens_hsa00052 | 0.40609670 |
| 151 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40022263 |
| 152 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38978479 |
| 153 | Retinol metabolism_Homo sapiens_hsa00830 | 0.37772126 |
| 154 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.36299121 |
| 155 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.36238938 |
| 156 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36215289 |

